Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-049430
Filing Date
2025-05-15
Accepted
2025-05-15 16:08:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11587
  Complete submission text file 0001104659-25-049430.txt   13433
Mailing Address 475 SANSOME STREET SUITE 1720 SAN FRANCISCO CA 94111
Business Address 475 SANSOME STREET SUITE 1720 SAN FRANCISCO CA 94111 415-281-1022
PFM Health Sciences, LP (Filed by) CIK: 0001442756 (see all company filings)

EIN.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 400 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 642-6670
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

EIN.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91714 | Film No.: 25952925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)